FDA Warning to Abbott on St. Jude Pacemakers and Defibrillators

On April 12, 2017 the FDA issued a warning letter to Abbott criticizing its failure to properly investigate and resolve risks related to its St. Jude implanted heart devices, including cybersecurity threats and a battery malfunction linked to two patient deaths.

Read the letter here.

Comments are closed.